Dupilumab: A review of its use in the treatment of atopic dermatitis

Journal of the American Academy of Dermatology
Melinda J GooderhamKim A Papp

Abstract

Atopic dermatitis (AD) is a chronic, pruritic immune-mediated inflammatory dermatosis characterized by a T helper 2 (Th2) immune response phenotype and may be associated with systemic inflammation. Dupilumab is an interleukin 4 (IL-4) receptor α-antagonist that inhibits IL-4 and IL-13 signaling through blockade of the shared IL-4α subunit. Blockade of IL-4/13 is effective in reducing Th2 response. Dupilumab has recently been approved in the United States and Europe for the treatment of adult patients with moderate-to-severe AD. Clinical trials have shown that adults with moderate-to-severe AD who receive weekly or biweekly dupilumab injections have significantly improved clinical and patient-reported outcomes, including Eczema Area Severity Index, SCORing Atopic Dermatitis, Dermatology Life Quality Index, and itch Numeric Rating Scale scores. Concomitant use of topical corticosteroids along with dupilumab results in a greater improvement in signs and symptoms of AD than with use of dupilumab alone. Biomarker analyses show that dupilumab modulates the AD molecular signature and other Th2-associated biomarkers. Common adverse events reported in the clinical trials were nasopharyngitis, upper respiratory tract infection, injection...Continue Reading

Associated Clinical Trials

Mar 21, 2018·Aya Ahmed Mohamed Abdelbary

Citations

Aug 8, 2018·Immunotherapy·Christine Bangert, Tamara Kopp
Nov 6, 2018·International Journal of Dermatology·Anwar Al Hammadi, Nisha V Parmar
Jun 13, 2019·The Journal of Dermatology·Jart A F OosterhavenMarie L A Schuttelaar
Jul 17, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·L LudriksoneS Schliemann
Jul 17, 2019·Experimental Dermatology·Martin Metz
Jun 20, 2019·JAMA Dermatology·Yuichi TerakiTomoo Fukuda
Sep 25, 2020·Expert Review of Clinical Immunology·Erika L CrowleyMelinda J Gooderham
Dec 29, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Mandy GutknechtMatthias Augustin
Feb 1, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Anniina T VirtanenOlli Silvennoinen
Aug 4, 2020·Expert Opinion on Investigational Drugs·Novin NezamololamaKim Papp
Nov 28, 2018·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·Johannes WohlrabThomas Werfel
May 28, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Thomas Litman
Feb 23, 2020·Immunotherapy·John V BoyleJoseph K Han
Jun 27, 2020·Current Opinion in Allergy and Clinical Immunology·Carlo LombardiGiovanni Passalacqua
Apr 16, 2020·International Journal of Molecular Sciences·Risa Tamagawa-Mineoka, Norito Katoh
Jul 2, 2020·Clinical, Cosmetic and Investigational Dermatology·Khaldon BodoorMotaz A Obeidat
Aug 11, 2020·International Journal of Dermatology·Nicole S KimMelinda J Gooderham
Nov 18, 2020·The Journal of Dermatological Treatment·Husein Husein-ElAhmed, Martin Steinhoff
Dec 23, 2020·Journal of Cutaneous Medicine and Surgery·Kayadri RatnarajahElena Netchiporouk
Sep 19, 2020·The Journal of Investigative Dermatology·Garrett J PatrickLloyd S Miller
Sep 10, 2020·Journal of Dermatological Science·Yoshiko MizukawaTetsuo Shiohara
May 23, 2020·The Ocular Surface·Canan Asli UtineEsen Akpek
Dec 31, 2020·International Journal of Molecular Sciences·Bo Young ChungHye One Kim
Feb 8, 2021·Respiratory Investigation·Ratoe SurayaYoshihiro Nishimura
Feb 17, 2021·The Journal of Dermatological Treatment·Ludovica ToffoliClaudio Conforti
Jan 24, 2021·Clinical and Experimental Dermatology·A M CartronS G Kwatra
Mar 16, 2021·The Open Respiratory Medicine Journal·Mohamed AbuzakoukIrfan Shafiq
Mar 18, 2021·Journal of the American Academy of Dermatology·Yu Wang, Joseph L Jorizzo
Oct 18, 2020·The Journal of Investigative Dermatology·Sohei MakitaHiroshi Nakajima
Mar 27, 2021·Expert Opinion on Biological Therapy·Maddalena NapolitanoCataldo Patruno
Apr 4, 2021·International Journal of Molecular Sciences·Reiko KageyamaYoshiki Tokura
Mar 4, 2021·The British Journal of Dermatology·A CampanatiA Offidani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.